Cardiff Oncology (CRDF) Operating Margin (2016 - 2025)
Historic Operating Margin for Cardiff Oncology (CRDF) over the last 15 years, with Q3 2025 value amounting to 9978.33%.
- Cardiff Oncology's Operating Margin fell 23413600.0% to 9978.33% in Q3 2025 from the same period last year, while for Sep 2025 it was 10719.56%, marking a year-over-year decrease of 39835700.0%. This contributed to the annual value of 7123.13% for FY2024, which is 21826000.0% up from last year.
- Latest data reveals that Cardiff Oncology reported Operating Margin of 9978.33% as of Q3 2025, which was down 23413600.0% from 12212.4% recorded in Q2 2025.
- Cardiff Oncology's 5-year Operating Margin high stood at 5333.17% for Q1 2024, and its period low was 14964.86% during Q1 2022.
- In the last 5 years, Cardiff Oncology's Operating Margin had a median value of 8325.83% in 2024 and averaged 9522.92%.
- As far as peak fluctuations go, Cardiff Oncology's Operating Margin surged by 91873100bps in 2024, and later tumbled by -78613200bps in 2025.
- Over the past 5 years, Cardiff Oncology's Operating Margin (Quarter) stood at 7162.41% in 2021, then fell by -2bps to 7337.5% in 2022, then increased by 10bps to 6623.08% in 2023, then fell by -26bps to 8325.83% in 2024, then fell by -20bps to 9978.33% in 2025.
- Its Operating Margin was 9978.33% in Q3 2025, compared to 12212.4% in Q2 2025 and 13194.5% in Q1 2025.